Argent BioPharma MGCLF Stock
Argent BioPharma Price Chart
Argent BioPharma MGCLF Financial and Trading Overview
| Argent BioPharma stock price | 0.28 USD |
| Previous Close | 0.0044 USD |
| Open | 0.0044 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0044 - 0.0044 USD |
| 52 Week Range | 0.0036 - 0.02 USD |
| Volume | 2.78K USD |
| Avg. Volume | 238.35K USD |
| Market Cap | 14.74M USD |
| Beta (5Y Monthly) | 1.254406 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.09 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MGCLF Valuation Measures
| Enterprise Value | 20.85M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0631778 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.334 |
| Enterprise Value/EBITDA | -1.273 |
Trading Information
Argent BioPharma Stock Price History
| Beta (5Y Monthly) | 1.254406 |
| 52-Week Change | -70.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.0036 USD |
| 50-Day Moving Average | 0.005442 USD |
| 200-Day Moving Average | 0.0078872 USD |
MGCLF Share Statistics
| Avg. Volume (3 month) | 238.35K USD |
| Avg. Daily Volume (10-Days) | 24.3K USD |
| Shares Outstanding | 3.35B |
| Float | 2.54B |
| Short Ratio | N/A |
| % Held by Insiders | 11.82% |
| % Held by Institutions | 11.46% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -342.52% |
| Gross Margin | 24.71% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.50% |
| Return on Equity (ttm) | -307.40% |
Income Statement
| Revenue (ttm) | 4.81M USD |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | 3.10% |
| Gross Profit (ttm) | 562.87K USD |
| EBITDA | -16385803 USD |
| Net Income Avi to Common (ttm) | -23344456 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.13M USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 10.03M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.392 |
| Book Value Per Share (mrq) | -0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13518810 USD |
| Levered Free Cash Flow (ttm) | -8994122 USD |
Profile of Argent BioPharma
| Country | United States |
| State | WA |
| City | West Perth |
| Address | 1202 Hay Street |
| ZIP | 6005 |
| Phone | 61 8 6382 3390 |
| Website | https://mgcpharma.com.au |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.
Q&A For Argent BioPharma Stock
What is a current MGCLF stock price?
Argent BioPharma MGCLF stock price today per share is 0.28 USD.
How to purchase Argent BioPharma stock?
You can buy MGCLF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Argent BioPharma?
The stock symbol or ticker of Argent BioPharma is MGCLF.
Which industry does the Argent BioPharma company belong to?
The Argent BioPharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Argent BioPharma have in circulation?
The max supply of Argent BioPharma shares is 47.06M.
What is Argent BioPharma Price to Earnings Ratio (PE Ratio)?
Argent BioPharma PE Ratio is now.
What was Argent BioPharma earnings per share over the trailing 12 months (TTM)?
Argent BioPharma EPS is -2.09 USD over the trailing 12 months.
Which sector does the Argent BioPharma company belong to?
The Argent BioPharma sector is Healthcare.